MarketCap
Kala Pharmaceuticals KALA
€ 0.32
0.86%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
8.15 M |
Marktkapitalisierung |
$ 2.93 M |
EBITDA (LTM) |
$ -38.8 M |
P/E (LTM) |
-0.154079 |
P/S (LTM) |
- |
EPS (LTM) |
-3.31 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Matinas BioPharma Holdings
MTNB
|
$ 2.82 | 6.82 % | $ 15.4 M | NYSE American | USA |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Neurocrine Biosciences
NBIX
|
$ 144.21 | 0.72 % | $ 14.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 25.1 | 0.16 % | $ 1.2 T | Nasdaq Global Select Market |  France |
 |
NuCana plc
NCNA
|
$ 1.06 | 2.75 % | $ 11.9 B | Nasdaq Global Select Market |  Britain |
 |
Minerva Neurosciences
NERV
|
$ 3.32 | 1.22 % | $ 28.1 M | Nasdaq Global Market | USA |
 |
Nektar Therapeutics
NKTR
|
$ 42.22 | 2.2 % | $ 712 M | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 2.53 | 0.59 % | $ 187 M | Nasdaq Global Select Market | USA |
 |
NanoViricides
NNVC
|
$ 1.45 | 13.28 % | $ 29.3 M | NYSE American | USA |
 |
Nurix Therapeutics
NRIX
|
$ 22.88 | 0.09 % | $ 1.98 B | Nasdaq Global Select Market,SPB | USA |
 |
Nuvation Bio
NUVB
|
$ 4.95 | 1.07 % | $ 1.69 B | NYSE | USA |
 |
Novavax
NVAX
|
$ 12.56 | 20.08 % | $ 2.03 B | Nasdaq Global Select Market | USA |
 |
Novo Nordisk A/S
NVO
|
$ 37.54 | 0.59 % | $ 167 B | NYSE |  Danmark |
 |
Novartis AG
NVS
|
$ 140.93 | 0.01 % | $ 273 B | NYSE |  Schweiz |
 |
NextCure
NXTC
|
$ 5.05 | 0.59 % | $ 14.4 M | Nasdaq Global Select Market | USA |
 |
Ocugen
OCGN
|
$ 1.04 | 1.96 % | $ 325 M | Nasdaq Capital Market | USA |
 |
Ocular Therapeutix
OCUL
|
$ 7.25 | 4.17 % | $ 1.36 B | Nasdaq Global Select Market | USA |
 |
Oragenics
OGEN
|
$ 0.49 | 1.25 % | $ 1.06 M | NYSE American | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 8.25 | 0.3 % | $ 718 M | Nasdaq Global Select Market | USA |
 |
Omeros Corporation
OMER
|
$ 18.9 | 1.56 % | $ 1.2 B | Nasdaq Global Select Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.6 | 1.21 % | $ 57.5 M | Nasdaq Global Select Market |  Canada |
 |
ORIC Pharmaceuticals
ORIC
|
$ 12.49 | 2.34 % | $ 1.1 B | Nasdaq Global Select Market | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 4.55 | 1.34 % | $ 188 M | Nasdaq Global Select Market |  Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.6 | 0.42 % | $ 20.9 M | Nasdaq Global Select Market | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.34 | 0.21 % | $ 305 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 4.09 | 0.73 % | $ 13.1 M | Nasdaq Global Select Market | USA |
 |
Puma Biotechnology
PBYI
|
$ 9.67 | 1.68 % | $ 484 M | Nasdaq Global Select Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.49 | 0.62 % | $ 1.95 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 73.82 | 30.7 % | $ 10 B | Nasdaq Global Select Market | USA |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.2 | 60.32 % | $ 55.7 M | Nasdaq Capital Market | USA |
 |
Pfizer
PFE
|
$ 27.41 | 0.02 % | $ 156 B | NYSE,SPB | USA |
 |
Precigen
PGEN
|
$ 7.74 | 4.02 % | $ 2.42 B | Nasdaq Global Select Market | USA |
 |
Pharming Group N.V.
PHAR
|
$ 9.8 | 0.51 % | $ 6.75 B | Nasdaq Global Select Market |  Niderland |
|
Phathom Pharmaceuticals
PHAT
|
$ 6.7 | 1.77 % | $ 489 M | Nasdaq Global Select Market,SPB | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.99 | 0.6 % | $ 5.92 M | Nasdaq Capital Market | USA |
 |
Pliant Therapeutics
PLRX
|
$ 1.03 | 0.48 % | $ 63.2 M | Nasdaq Global Select Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.71 | 0.37 % | $ 213 M | NYSE American | Israel |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.78 | 2.29 % | $ 93.5 M | Nasdaq Global Select Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 283.56 | 3.0 % | $ 6.38 B | Nasdaq Global Select Market,SPB | USA |
 |
PainReform Ltd.
PRFX
|
$ 0.88 | 0.04 % | $ 570 K | Nasdaq Capital Market | Israel |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.77 | 2.72 % | $ 290 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.67 | 2.14 % | $ 176 M | Nasdaq Global Market | Niderland |
 |
Prothena Corporation plc
PRTA
|
$ 8.27 | 0.35 % | $ 445 M | Nasdaq Global Select Market,SPB | USA |
 |
PTC Therapeutics
PTCT
|
$ 63.65 | 0.3 % | $ 5.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 140.63 | 0.41 % | $ 8.94 B | Nasdaq Global Select Market | USA |
 |
Pulmatrix
PULM
|
$ 1.48 | 0.64 % | $ 5.41 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 5.2 | 0.19 % | $ 85 M | Nasdaq Global Select Market | Israel |
 |
Repare Therapeutics
RPTX
|
- | - | $ 112 M | Nasdaq Global Select Market | Canada |
 |
uniQure N.V.
QURE
|
$ 22.8 | 0.39 % | $ 1.31 B | Nasdaq Global Select Market | Niderland |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.61 | 1.95 % | $ 290 M | Nasdaq Global Select Market | USA |